NasdaqGM - Nasdaq Real Time Price USD

Gain Therapeutics, Inc. (GANX)

3.0700 -0.0800 (-2.54%)
As of 11:06 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
55.1800
55.1800
140.1080
164.9940
28.8810
Operating Expense
22,308.3130
22,308.3130
17,917.1530
13,991.1670
3,508.3300
Operating Income
-22,253.1330
-22,253.1330
-17,777.0450
-13,826.1730
-3,479.4490
Net Non Operating Interest Income Expense
494.2340
494.2340
375.3570
12.4950
3.6370
Other Income Expense
-429.3460
-429.3460
-96.0740
-72.9200
-96.4840
Pretax Income
-22,188.2450
-22,188.2450
-17,497.7620
-13,886.5980
-3,572.2960
Tax Provision
79.2750
79.2750
92.9760
4.0080
5.3860
Net Income Common Stockholders
-22,267.5200
-22,267.5200
-17,590.7380
-13,890.6060
-3,577.6820
Diluted NI Available to Com Stockholders
-22,267.5200
-22,267.5200
-17,590.7380
-13,890.6060
-3,577.6820
Basic EPS
-1.71
--
-1.48
-1.37
-1.33
Diluted EPS
-1.71
--
-1.48
-1.37
-1.33
Basic Average Shares
13,011.3610
--
11,883.3680
10,165.4040
2,681.4080
Diluted Average Shares
13,011.3610
--
11,883.3680
10,165.4040
2,681.4080
Total Operating Income as Reported
-22,253.1330
-22,253.1330
-17,777.0450
-13,826.1730
-3,479.4490
Total Expenses
22,308.3130
22,308.3130
17,917.1530
13,991.1670
3,508.3300
Net Income from Continuing & Discontinued Operation
-22,267.5200
-22,267.5200
-17,590.7380
-13,890.6060
-3,577.6820
Normalized Income
-21,928.3367
-21,928.3367
-17,495.1732
-13,817.6860
-3,507.2487
Interest Income
494.2340
494.2340
375.3570
--
--
Net Interest Income
494.2340
494.2340
375.3570
12.4950
3.6370
EBIT
-22,253.1330
-22,253.1330
-17,777.0450
-13,826.1730
-3,479.4490
EBITDA
-22,169.5540
-22,169.5540
-17,712.8770
-13,810.6890
-3,469.8570
Reconciled Depreciation
83.5790
83.5790
64.1680
15.4840
9.5920
Net Income from Continuing Operation Net Minority Interest
-22,267.5200
-22,267.5200
-17,590.7380
-13,890.6060
-3,577.6820
Total Unusual Items Excluding Goodwill
-429.3460
-429.3460
-96.0740
-72.9200
-96.4840
Total Unusual Items
-429.3460
-429.3460
-96.0740
-72.9200
-96.4840
Normalized EBITDA
-21,740.2080
-21,740.2080
-17,616.8030
-13,737.7690
-3,373.3730
Tax Rate for Calcs
0.0002
0.0002
0.0000
--
0.0003
Tax Effect of Unusual Items
-90.1627
-90.1627
-0.5092
--
-26.0507
12/31/2020 - 3/19/2021
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

COYA Coya Therapeutics, Inc.
8.48
+0.47%
 
GLSI Greenwich LifeSciences, Inc.
12.83
-0.47%
 
ANRO Alto Neuroscience, Inc.
13.53
+0.22%
 
OTLK Outlook Therapeutics, Inc.
8.43
+1.69%
 
CALC CalciMedica, Inc.
4.0100
-0.25%
 
RZLT Rezolute, Inc.
3.3300
+0.91%
 
TARA Protara Therapeutics, Inc.
2.7400
-0.36%
 
CUE Cue Biopharma, Inc.
1.5300
-3.16%
 
TRDA Entrada Therapeutics, Inc.
12.06
+1.26%
 
PCSA Processa Pharmaceuticals, Inc.
1.6150
+3.53%